Third quarter results for fiscal year 2026 at Medtrade exhibitor Resmed revealed a revenue increase of 11% to $1.4 billion.

The Medtrade prize went to sleep tech innovator SleepRes for its Kricket PAP, which uses the newly developed Kairos Positive Airway Pressure (KPAP) to treat OSA.

When it comes to POCs, the details matter. "We want to license to the manufacturers and enable them to have a product that does not look like everybody else.”

Resmed results showed a revenue increase of 11% to $1.4 billion. Income from operations increased 18%. 

It is not uncommon for DME suppliers and sleep labs to work together in the provision of therapeutic equipment to patients who test positive for OSA.

Company officials attributed a 3Q revenue jump to continued higher demand from international and domestic business-to-business customers.